TI
QTTB icon

Trexquant Investment’s Q32 Bio QTTB Stock Holding History

Trexquant Investment’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,790
Closed -$348K – 1903
2024
Q3 		$348K Buy
+7,790
New +$286K ﹤0.01% 1321
2022
Q1 		– Sell
-1,152
Closed -$76K – 1797
2021
Q4 		$76K Buy
+1,152
New +$112K ﹤0.01% 1247
2021
Q2 		– Sell
-1,046
Closed -$177K – 1567
2021
Q1 		$177K Buy
+1,046
New +$220K 0.02% 993

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Trexquant Investment's QTTB Position: Q4 2024 in Review

Trexquant Investment sold out of Q32 Bio (QTTB) in Q4 2024, closing a stake of 7,790 shares — an estimated $348K sold.

Trexquant Investment first reported a position in QTTB in Q1 2021 and held it in 3 quarters. The position peaked at $348K in Q3 2024. 92 funds tracked by Wall St. Rank hold QTTB as of Q4 2024.

  • Trexquant Investment reported no remaining Q32 Bio position as of Q4 2024 after selling out during the quarter.
  • Trexquant Investment sold 7,790 Q32 Bio shares in Q4 2024, an estimated $348K.
  • Trexquant Investment first reported a position in Q32 Bio in Q1 2021 and held it in 3 quarters.
  • Trexquant Investment's Q32 Bio position peaked at $348K in Q3 2024.
  • 92 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2024.

Based on Trexquant Investment's 13F filing for Q4 2024, filed 12 Feb 2025.